A retrospective, observational study comparing the four available immunomodulatory treatments for relapsing-remitting multiple sclerosis
Author:
Publisher
Wiley
Subject
Clinical Neurology,Neurology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1468-1331.2003.00669.x/fullpdf
Reference16 articles.
1. A comparison of observational studies and randomized, controlled studies;Benson;N Eng J Med,2000
2. Recombinant human interferon beta in relapsing-remitting multiple sclerosis: a review of the major clinical trials;Chofflon;Eur J Neurol,2000
3. Independent Comparison of Interferon (INCOMIN) Trial Study Group. Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis: results of a 2-year prospective randomised multicentre study (INCOMIN);Durelli;Lancet,2002
4. Interferons in relapsing-remitting multiple sclerosis: a systematic review;Filippini;Lancet,2003
5. Comparison of immunomodulatory treatment of relapsing-remitting multiple sclerosis (RRMS). A prospective open study in 498 MS-patients treated with interferon beta (IFNβ) 1-B, IFNβ 1-A i.m., IFNβ 1-A s.c., glatiramer acetate (copaxone) or immunoglobuline M;Firzlaff;J Neurol,2000
Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Non-compliance with disease modifying therapies in patients with Multiple Sclerosis: A qualitative analysis;Multiple Sclerosis and Related Disorders;2020-06
2. The inclusion of real world evidence in clinical development planning;Trials;2018-08-29
3. Modeling Approaches in Cost-Effectiveness Analysis of Disease-Modifying Therapies for Relapsing–Remitting Multiple Sclerosis: An Updated Systematic Review and Recommendations for Future Economic Evaluations;PharmacoEconomics;2018-07-03
4. Clinical, Radiological and Electrophysiological Comparison of Immunomodulatory Therapies in Multiple Sclerosis;Noro Psikiyatri Arsivi;2017-06-29
5. Comparative effectiveness of interferons in relapsing–remitting multiple sclerosis: a meta-analysis of real-world studies;Current Medical Research and Opinion;2017-01-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3